Clinical Trial Detail

NCT ID NCT02432274
Title Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements no
Sponsors Eisai Limited
Indications

osteosarcoma

thyroid cancer

Advanced Solid Tumor

Therapies

Etoposide

Lenvatinib

Cyclophosphamide

Age Groups: child

No variant requirements are available.